AcelRx Pharmaceuticals, Inc. (ACRX) Stock Overview
Explore AcelRx Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
AcelRx Pharmaceuticals, Inc. (ACRX)
Key Financials
Key Financials
Market Cap
14.6M
P/E Ratio
-4.21
EPS (TTM)
$-2.75
ROE
-0.93%
ACRX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of AcelRx Pharmaceuticals, Inc. (ACRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.21 and a market capitalization of 14.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.